Medacta Group Sa Stock Price Prediction
| MEDGF Stock | USD 83.91 0.00 0.00% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Medacta Group hype-based prediction, you can estimate the value of Medacta Group SA from the perspective of Medacta Group response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Medacta Group to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Medacta because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Medacta Group after-hype prediction price | USD 83.91 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Medacta |
Medacta Group After-Hype Price Prediction Density Analysis
As far as predicting the price of Medacta Group at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Medacta Group or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Medacta Group, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Medacta Group Estimiated After-Hype Price Volatility
In the context of predicting Medacta Group's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Medacta Group's historical news coverage. Medacta Group's after-hype downside and upside margins for the prediction period are 83.91 and 83.91, respectively. We have considered Medacta Group's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Medacta Group is very steady at this time. Analysis and calculation of next after-hype price of Medacta Group SA is based on 3 months time horizon.
Medacta Group Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Medacta Group is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medacta Group backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Medacta Group, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
83.91 | 83.91 | 0.00 |
|
Medacta Group Hype Timeline
Medacta Group SA is now traded for 83.91. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Medacta is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Medacta Group is about 0.0%, with the expected price after the next announcement by competition of 83.91. About 70.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 23rd of May 2022. Assuming the 90 days horizon the next forecasted press release will be uncertain. Check out Medacta Group Basic Forecasting Models to cross-verify your projections.Medacta Group Related Hype Analysis
Having access to credible news sources related to Medacta Group's direct competition is more important than ever and may enhance your ability to predict Medacta Group's future price movements. Getting to know how Medacta Group's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Medacta Group may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| STSEY | Stratec SE | 0.00 | 0 per month | 0.00 | (0.20) | 0.00 | 0.00 | 13.88 | |
| DRWKF | Drgerwerk AG Co | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IUSDF | AS ONE | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TTALF | Terveystalo Oyj | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SZUKF | Suzuken Co | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBOSY | EBOS Group Limited | 0.00 | 0 per month | 0.00 | (0.22) | 0.00 | 0.00 | 10.63 | |
| PHMMF | Pharma Mar SAU | 0.00 | 0 per month | 0.00 | (0.15) | 0.00 | (1.56) | 17.46 | |
| ZRSEF | Zur Rose Group | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OSSUY | ssur hf | 0.00 | 0 per month | 0.00 | 0.13 | 0.00 | 0.00 | 27.25 | |
| VTRLY | Vitrolife AB | 0.00 | 0 per month | 0.00 | (0.01) | 0.00 | 0.00 | 35.97 |
Medacta Group Additional Predictive Modules
Most predictive techniques to examine Medacta price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Medacta using various technical indicators. When you analyze Medacta charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Medacta Group Predictive Indicators
The successful prediction of Medacta Group stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Medacta Group SA, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Medacta Group based on analysis of Medacta Group hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Medacta Group's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Medacta Group's related companies.
Story Coverage note for Medacta Group
The number of cover stories for Medacta Group depends on current market conditions and Medacta Group's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Medacta Group is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Medacta Group's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for Medacta Pink Sheet analysis
When running Medacta Group's price analysis, check to measure Medacta Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medacta Group is operating at the current time. Most of Medacta Group's value examination focuses on studying past and present price action to predict the probability of Medacta Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medacta Group's price. Additionally, you may evaluate how the addition of Medacta Group to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |